Science Market Update

UC Davis Researchers Receive $1.5M to Study Immune Cells for Tumor Treatment

Posted by Laura Braden on Mon, Nov 06, 2017

White blood cells help the immune system protect the body from infections and diseases. Along with attacking infections, white blood cells also have the ability to bring other cells together to help in the fight. With these known abilities of white blood cells, life science researchers have been researching ways to amplify the abilities of these cells to target specific illnesses, such as tumors. 

Read More

Tags: CA, University of California Davis Medical Center, University of California Davis, Cancer Treatment, Immune System, UCDMC, Sacramento, NIH funding, 2018

UMass Researcher Granted $2.3M to Study Tuberculosis

Posted by Laura Braden on Fri, Nov 03, 2017

Tuberculosis (TB) is an infectious disease that affects nearly 1/3 of the world's population. Although eradication efforts have been undertaken, none have been successful and TB is still a leading cause around the world. Even though there are treatment methods for this infection, they are not always successful at killing the bacteria that cause TB. This provides life science researchers with more questions and research topics, to better understand the infection and bacteria and what causes treatments to work occasionally, but not always

Read More

Tags: tuberculosis, University of Massachusetts Amherst, new research funding, MA, NIH funding, Amherst, UMASS, 2018, TB Research

Washington University Receives $46M to Support Translational Research

Posted by Laura Braden on Tue, Oct 24, 2017

Washington University in St. Louis has 1 of 57 Institutes of Clinical and Translation Sciences (ICTS) in the United States. The ICTS at Washington University focuses on translating discoveries from both translation and clinical research into new treatments and therapies. The ICTS does not focus on just one area of life science research. Instead, researchers from all spectrums on the health sciences are able to use the institutes resources to further their work on topics like disease prevention and treatment. Training programs are also offered through the institute for researchers. (Image courtesy of P. David via Wikimedia Commons)

Read More

Tags: Washington University St. Louis, WashU, BioResearch Product Faire Event, MO, NIH funding, Clinical and Translational Research, 2018, clinical and translational research funding

UPenn Receives $22.6M for Materials Science Research

Posted by Laura Braden on Mon, Oct 23, 2017

Researchers within the Laboratory for Research on the Structure of Matter (LRSM) at the University of Pennsylvania have been conducting breakthroughs in the field of materials science since it opened in 1961. A leading center within the LRSM that helps with this breakthrough research, the NSF Materials Research Science and Engineering Center (MRSEC), was recently awarded a $22.6 million grant from the National Science Foundation (NSF) that will support materials research at UPenn over the next six years. (Image courtesy of WestCoastivieS via Wikimedia Commons)

Read More

Tags: University of Pennsylvania, UPenn, BioResearch Product Faire Event, PA, NIH funding, NIH award, NSF funding, Materials Research, 2018, Materials Science

$3.2M Granted to UGA for Vaccine Research

Posted by Laura Braden on Wed, Oct 11, 2017

Vaccine research is a field that is constantly growing and changing, from new vaccines being created to different vaccination methods being developed. With diseases changing and new diseases emerging, researchers around the world work tirelessly to create treatments. Researchers from the College of Veterinary Medicine at the University of Georgia, Athens recently received a grant of $3.2 million from the National Institutes of Health (NIH) to continue their work developing new vaccine platforms. (Image courtesy of John Keith via Wikimedia Commons)

Read More

Tags: University of Georgia Athens, vaccine research, UGA, BioResearch Product Faire Event, NIH funding, NIH grant, 2018, SAAVE

$8M Granted to UCLA to Study Cytomegalovirus and Kidney Transplants

Posted by Laura Braden on Thu, Oct 05, 2017

Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.

Read More

Tags: CA, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, 2017, cytomegalovirus

$11.5M Granted to Houston Scientists for Lymphoma Treatment Research

Posted by Laura Braden on Wed, Oct 04, 2017

Lymphoma is one of the most common types of cancer, with Non-Hodgkin Lymphoma making up about 4% of all cancer cases in the United States, according to the American Cancer Society. Although treatment methods like chemotherapy and radiation therapy are able to treat the cancer, researchers still actively study this cancer to gain a better understanding of it to develop new targeted treatment methods. 

Researchers from the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital have been studying new therapies for the cancer using T-cells, research that they will continue with the assistance of a new $11.5 million grant from the National Cancer Institute. (Image courtesy of TexasPathologistMSW ia Wikimedia Commons)

Read More

Tags: new research funding, cancer research, Texas Medical Center, tmc, Houston, TX, NIH funding, 2018, Lymphoma, Baylor College of Medicine

University of Arizona Granted $4.8M for Valley Fever Vaccine Research

Posted by Laura Braden on Thu, Sep 28, 2017

Valley Fever affects nearly 10,000 people in the United States each year, predominately in the Southwestern states of Arizona and California. This infection, caused by the fungus Coccidioide, affects different people in different ways: some get very ill while others are only mildly affected. However people are affected, there is no vaccine to cure the infection. A team of researchers from the University of Arizona, Tucson recently received a $4.8 million grant from the National Institute of Allergy and Infectious Disease (NIAID) to develop a vaccine for Valley Fever. 

Read More

Tags: new research funding, AZ, UAZ, BioResearch Product Faire Event, Tucson, NIH funding, University of Arizona Tucson, 2017, Valley Fever

UAB Center for AIDS Research Committed to Stopping HIV by 2030

Posted by Rebecca Partridge on Tue, Aug 22, 2017

According to an article for UAB News, 40% of individuals infected with HIV are not currently receiving antiretroviral therapy, which means their disease is not suppressed. The University of Alabama, Birmingham’s Center for AIDS Research recently partnered with state and local agencies in signing the Paris Declaration to eliminate the spread of HIV/AIDS by 2030. Birmingham is the 13th U.S. city to commit to achieving the Declaration’s goals.

Read More

Tags: Bioresearch funding, AIDS Research, Alabama, University of Alabama, University of Alabama Birmingham, UAlab, UAB, NIH funding, University of Alabama at Birmingham, BioResearch Product Faire, Bioresearch Grant, NIH awards 2017

UC Irvine: $9.6M in NIAID Research Funding for Malaria Study

Posted by Rebecca Partridge on Thu, Jun 22, 2017

The National Institute of Allergy & Infectious Diseases (NIAID) awarded University of California, Irvine $9.6 million to study the impact of environmental changes on malaria in sub-Saharan Africa. This research funding establishes UCI as one of the International Centers of Excellence for Malaria Research (ICEMR).

Read More

Tags: University of California Irvine, malaria, Research Funding, Laboratory Equipment Supplier, Lab Product Sales, NIH funding, UCI, UC Irvine, BioResearch Product Faire, 2017 research funding

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News